Medtronic (MDT) Tops Q4 EPS by 6c; Sees Larger FX Impact in FY16
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Wedbush Raised Price Target on Medtronic (MDT) Following FY16 Guidance; Maintains Neutral
June 3, 2015 9:03 AM EDTWedbush maintains a Neutral rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $79.00 (from $75.00), following Q4 results and guidance. MDT reported FY4Q15 revenue of $7.3 billion (as preannounced). Reported adjusted EPS of $1.16 was 3c ahead of the upper end of its... More
Medtronic (MDT) PT Bumped to $91 at Needham & Company Post Q4
June 2, 2015 1:08 PM EDTNeedham & Company analyst Mike Matson reiterated a Buy rating and bumped his price target on Medtronic, Inc. (NYSE: MDT) to $91.00 (from $90.00) following Q4 results.
Analyst Matson commented, "MDT's F4Q15 revenue was consistent with its 5/20/15 preannouncement while its EPS came in ahead of... More
